The University of South Alabama Health Mitchell Cancer Institution has discovered a vulnerability in ovarian cancer cells. ...

Researchers in California have developed a blood test, OvaPrint, to help detect early-stage ovarian cancer. After successful testing, OvaPrint could be commercially available in two years.

A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to ...

Characterization of immune response during ovarian tumor progression. mCherry+ TKO mouse ovarian cancer cells were injected i.p. in C57BL/6 immunocompetent mice (n=50) or immunocompromised athymic ...

Microplastics have been detected in human reproductive fluids, with researchers finding them in 69% of female and 55% of male ...

Trabert’s team looked at two different studies — one in Poland, which involved 278 ovarian cancer cases and 556 women without cancer, and a U.S. study comparing 160 ovarian cancer patients and ...

Women may crave and drink more alcohol during certain times of their menstrual cycle, a new study suggests. Researchers say ...

New study from ACOG shows use of cycle-tracking apps alone cannot accurately predict ovulation. ... For example, the First Response Ovulation Test Kit will establish a woman’s unique hormone ...

An Australian study of the most downloaded fertility apps has found over half didn't perform well at predicting ovulation — which is exactly what many users are using these apps for.

(RTTNews) - Sutro Biopharma Inc.'s (STRO) interim phase I updated clinical data for a dose-escalation study of antibody drug-conjugate STRO-002 in ovarian cancer has been encouraging.

Smelling samples from ovulating women also encouraged men to make riskier decisions in one study. Ovulation typically happens around the 14th day of a 28-day menstrual cycle.